Citation: Ph. Douglas et Pc. Block, Corrected QT interval prolongation associated with intravenous haloperidolin acute coronary syndromes, CATHET C IN, 50(3), 2000, pp. 352-355
Authors:
Kruger, WD
Evans, AA
Wang, LQ
Malinow, MR
Duell, PB
Anderson, PH
Block, PC
Hess, DL
Graf, EE
Upson, B
Citation: Wd. Kruger et al., Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid, MOL GEN MET, 70(1), 2000, pp. 53-60
Authors:
Williams, DO
Holubkov, R
Yeh, WL
Bourassa, MG
Al-Bassam, M
Block, PC
Coady, P
Cohen, H
Cowley, M
Dorros, G
Faxon, D
Holmes, DR
Jacobs, A
Kelsey, SF
King, SB
Myler, R
Slater, J
Stanek, V
Vlachos, HA
Detre, KM
Citation: Do. Williams et al., Percutaneous coronary intervention in the current era compared with 1985-1986 - The National Heart, Lung, and Blood Institute Registries, CIRCULATION, 102(24), 2000, pp. 2945-2951
Authors:
Block, PC
Peterson, EC
Krone, R
Kesler, K
Hannan, E
O'Connor, GT
Detre, K
Citation: Pc. Block et al., Identification of variables needed to risk adjust outcomes of coronary interventions: Evidence-based guidelines for efficient data collection. (vol 32, pg 275, 1998), J AM COL C, 34(2), 1999, pp. 613-613
Authors:
Pathan, AZ
Mahdi, NA
Leon, MN
Lopez-Cuellar, J
Simosa, H
Block, PC
Harrell, L
Palacios, IF
Citation: Az. Pathan et al., Is redo percutaneous mitral balloon valvuloplasty (PMV) indicated in patients with post-PMV mitral restenosis?, J AM COL C, 34(1), 1999, pp. 49-54
Citation: Pc. Block, Editorial comment - The ill wind of transient vessel closure during percutaneous transluminal coronary angioplasty, J AM COL C, 33(1), 1999, pp. 79-81